Own the gold standard ✨ in financial data & analytics

Subscribe for $2
Overview
Profile
Health Sciences - Stock

Health Sciences Stock

IWKS
US0010582056

Price

0.50
Today +/-
+0
Today %
+0 %
P

Health Sciences Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Health Sciences, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Health Sciences from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Health Sciences’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Health Sciences. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Health Sciences’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Health Sciences’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Health Sciences’s growth potential.

Health Sciences Revenue, EBIT and net profit per share

DateHealth Sciences RevenueHealth Sciences EBITHealth Sciences Net Income
200834.28 M undefined-4.41 M undefined-11.05 M undefined
200728.72 M undefined-933,000 undefined-4.67 M undefined
200625 M undefined1.04 M undefined1 M undefined
200523.14 M undefined1.35 M undefined1.9 M undefined
200419.83 M undefined1.45 M undefined1.35 M undefined
200318.04 M undefined0 undefined-1.52 M undefined
200220.09 M undefined390,000 undefined90,000 undefined
200124.05 M undefined-380,000 undefined-1.74 M undefined
200025.37 M undefined-430,000 undefined-810,000 undefined
199929.37 M undefined-930,000 undefined-2.21 M undefined
199833.77 M undefined520,000 undefined-3.33 M undefined
199737.05 M undefined2.13 M undefined1.55 M undefined
199636.53 M undefined1.54 M undefined700,000 undefined
199526.59 M undefined1.52 M undefined920,000 undefined
199430.51 M undefined180,000 undefined-4.18 M undefined
199338.26 M undefined1.57 M undefined-1.26 M undefined
199238.26 M undefined970,000 undefined-530,000 undefined
199138.03 M undefined10,000 undefined-1.19 M undefined
199048.29 M undefined2.75 M undefined420,000 undefined
198945.45 M undefined2.31 M undefined-190,000 undefined

Health Sciences Stock Ratios

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (k)NET INCOME GROWTH (%)SHARES (k)DOCUMENTS
19831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008
1014171619434548383838302636373329252420181923242834
-40.0021.43-5.8818.75126.324.656.67-20.83---21.05-13.3338.462.78-10.81-12.12-13.79-4.00-16.67-10.005.5621.054.3516.6721.43
40.0042.8629.4131.2531.5832.5631.1131.2526.3228.9528.9530.0034.6233.3332.4330.3027.5928.0029.1730.0033.3336.8434.7837.5035.7141.18
4655614141510111199121210877667891014
1201132200101120000001110-4
10.0014.29-6.255.266.984.444.17--2.63-3.852.785.41------5.264.354.17--11.76
00000000-1,0000-1,000-4,000001,000-3,000-2,0000-1,0000-1,0001,0001,0001,000-4,000-11,000
-----------300.00----400.00-33.33-----200.00---500.00175.00
101010101010101010101010102010202020202018.5419.2619.7721.0327.2735.86
- - - - - - - - - - - - - - - - - - - - - - - - - -
Details

Keystats

ⓘ

Revenue and Growth

The Health Sciences Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Health Sciences is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Health Sciences provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Health Sciences's financial health and stability.

Assets

Health Sciences's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Health Sciences must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Health Sciences after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Health Sciences's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (k)DEPRECIATION (k)DEFERRED TAXES (k)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (k)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (k)CASH FLOW FROM OTHER INVESTING ACTIVITIES (k)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
19861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008
00000-1,0000-1,000-4,000001,000-3,000-2,0000-1,0000-1,0001,0001,0001,000-4,000-11,000
01,0001,0001,0001,0001,0001,0000000000000000001,000
00000000000000000000001,000
0010013021-32-10110000000
00000002200031000100035
00122111100000000000001
0000000000000000000001,0000
1231013112-15001110010-1-2
00000000000000000000000
-2,0000-13,0000000001,000-3,000-2,000-1,00000000000-17,0000
-2,0000-13,0000000001,000-3,000-1,000000000000-17,0000
00000000000000000000000
20800-1-3-1-1-45-400-1-1-10-10071
00000000002000000000580
20800-1-3-1-1-47-400-1-1-10-104141
-----------------------
00000000000000000000000
01-200000002-1-100000004-40
0.672.312.770.610.281.113.550.961.492.78-1.415.25-1.140.151.420.821.120.240.770.950.73-1.8-2.5
00000000000000000000000

Health Sciences stock margins

The Health Sciences margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Health Sciences. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Health Sciences.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Health Sciences's sales revenue. A higher gross margin percentage indicates that the Health Sciences retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Health Sciences's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Health Sciences's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Health Sciences's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Health Sciences. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Health Sciences's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Health Sciences Margin History

Health Sciences Gross marginHealth Sciences Profit marginHealth Sciences EBIT marginHealth Sciences Profit margin
200842.28 %-12.86 %-32.23 %
200737.8 %-3.25 %-16.27 %
200637.31 %4.14 %4.02 %
200538.67 %5.85 %8.21 %
200438.6 %7.33 %6.79 %
200334.24 %0 %-8.4 %
200233.9 %1.94 %0.45 %
200131.56 %-1.58 %-7.23 %
200030.59 %-1.69 %-3.19 %
199930.34 %-3.17 %-7.52 %
199831.21 %1.54 %-9.86 %
199732.66 %5.75 %4.18 %
199633.12 %4.22 %1.92 %
199534.45 %5.72 %3.46 %
199430.97 %0.59 %-13.7 %
199331.05 %4.1 %-3.29 %
199228.93 %2.54 %-1.39 %
199126.3 %0.03 %-3.13 %
199031.81 %5.69 %0.87 %
198932.67 %5.08 %-0.42 %

Health Sciences Stock Sales Revenue, EBIT, Earnings per Share

The Health Sciences earnings per share therefore indicates how much revenue Health Sciences has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Health Sciences earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Health Sciences's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Health Sciences’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Health Sciences's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Health Sciences Revenue, EBIT and net profit per share

DateHealth Sciences Sales per ShareHealth Sciences EBIT per shareHealth Sciences Earnings per Share
2008955.94 undefined-122.89 undefined-308.11 undefined
20071,053.17 undefined-34.21 undefined-171.32 undefined
20061,188.68 undefined49.26 undefined47.74 undefined
20051,170.21 undefined68.49 undefined96.11 undefined
20041,029.75 undefined75.49 undefined69.89 undefined
2003973.25 undefined0 undefined-81.72 undefined
20021,004.5 undefined19.5 undefined4.5 undefined
20011,202.5 undefined-19 undefined-87 undefined
20001,268.5 undefined-21.5 undefined-40.5 undefined
19991,468.5 undefined-46.5 undefined-110.5 undefined
19981,688.5 undefined26 undefined-166.5 undefined
19973,705 undefined213 undefined155 undefined
19961,826.5 undefined77 undefined35 undefined
19952,659 undefined152 undefined92 undefined
19943,051 undefined18 undefined-418 undefined
19933,826 undefined157 undefined-126 undefined
19923,826 undefined97 undefined-53 undefined
19913,803 undefined1 undefined-119 undefined
19904,829 undefined275 undefined42 undefined
19894,545 undefined231 undefined-19 undefined

Health Sciences business model

The Health Sciences Corp is a company that has been active in the biotechnology industry since 1997. It was founded with the goal of developing practical and innovative solutions for medical problems. The company is based in Toronto, Canada, and operates worldwide. The business model of the Health Sciences Corp includes several divisions, all focused on the field of biotechnology. The main divisions are the development of diagnostic tests, drug development, and the production of medical devices. In the field of diagnostic tests, the Health Sciences Corp offers various products that are intended to contribute to faster and more accurate disease diagnosis. An example of this is the reliable blood glucose test, which is particularly used in the diagnosis of diabetes and other metabolic diseases. The company also offers tests for the detection of infectious diseases such as HIV or hepatitis. In the area of drug development, the Health Sciences Corp focuses on developing innovative solutions for particularly difficult-to-treat diseases. These include cancer, autoimmune, and neurodegenerative diseases. Both completely new active substances and novel combinations of existing therapies are developed for this purpose. In addition to drug development, the company also works on the production of medical products. This includes implants as well as devices for monitoring vital parameters. An example of this is the wireless sensor for monitoring heart rhythm disorders, which is applied to the patient's skin and transfers data to the doctor's mobile phone. Over the years, the Health Sciences Corp has received numerous awards and prizes for technological innovations as well as medical research. The company makes a particularly significant contribution to cancer research. It works closely with renowned research institutions and universities, thus constantly contributing to new findings. The knowledge gained in the process also flows into the development of new therapies. In 2016, the Health Sciences Corp founded a subsidiary called MaRS Innovation, which aims to commercialize technology from Canadian universities. The goal is to transform new technologies that have been researched in universities into commercial products and services. The vision of the Health Sciences Corp is to contribute to sustainably improving healthcare for people worldwide through innovative therapies and medications. In addition, the company places great importance on adhering to ethical and moral standards and behaving respectfully towards the environment and society. Overall, the company has an excellent reputation in the biotechnology industry and is considered a pioneer in the development of practical and innovative solutions for medical problems. Health Sciences is one of the most popular companies on Eulerpool.com.

Health Sciences SWOT Analysis

Strengths

Health Sciences Corp has a strong reputation in the healthcare industry due to its track record of providing high-quality medical services and expertise. The organization boasts a team of highly skilled and experienced professionals in various healthcare disciplines.

The company has state-of-the-art facilities and advanced medical technology, allowing them to deliver advanced and innovative treatments to patients. This technological advantage enhances their ability to diagnose and treat various medical conditions effectively.

Weaknesses

Health Sciences Corp faces challenges in terms of high operating costs. The maintenance of modern facilities and cutting-edge technology requires significant financial resources, impacting the organization's financial stability and profitability.

Additionally, the rapid advancements in medical technology necessitate continuous staff training to keep up with the latest practices. This poses a challenge for the company in terms of maintaining a knowledgeable and up-to-date workforce.

Opportunities

Health Sciences Corp can leverage its strong reputation and expertise to expand its services and reach new markets. The increasing demand for specialized healthcare services presents an opportunity for the company to diversify its offerings and attract a broader range of patients.

The organization can also explore collaborations and partnerships with pharmaceutical companies, research institutions, and other healthcare providers to further enhance its capabilities and develop new treatment options.

Threats

Health Sciences Corp faces intense competition from other healthcare providers, both locally and nationally. This competition may affect their market share and patient retention rates, necessitating the implementation of strategic marketing initiatives to maintain a competitive edge.

Changes in healthcare regulations and policies can also pose a threat to the company. Adapting to new compliance standards and ensuring patient privacy and data security may require additional investments and resources.

Health Sciences valuation based on historical P/E ratio, EBIT, and P/S ratio.

Health Sciences shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Health Sciences earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Health Sciences's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Health Sciences’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Health Sciences's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Health Sciences.

Health Sciences stock: Frequently Asked Questions

What values and corporate philosophy does Health Sciences represent?

Health Sciences Corp is committed to upholding certain values and embracing a specific corporate philosophy. The company focuses on promoting excellence, innovation, and ethical business practices. With a strong dedication to providing high-quality healthcare solutions, Health Sciences Corp puts patients at the center of its operations. The company also prioritizes collaboration and teamwork among its employees, ensuring a unified approach for delivering effective medical services. By constantly seeking advancements in medical technology and research, Health Sciences Corp aims to make meaningful contributions to the healthcare industry and improve patient outcomes.

In which countries and regions is Health Sciences primarily present?

Health Sciences Corp primarily operates in the United States, with its headquarters located in California. It has a strong presence across various regions within the country, including New York, Texas, Florida, and Illinois. The company's focus on providing innovative healthcare solutions has enabled it to establish a significant market presence in the US healthcare industry. Health Sciences Corp continues to expand its reach and influence within the American market, enhancing its position as a leading provider of healthcare services and solutions.

What significant milestones has the company Health Sciences achieved?

Health Sciences Corp has achieved several significant milestones. The company has made remarkable progress in the field of medical research and development. With its cutting-edge technologies, Health Sciences Corp has successfully launched innovative products that have revolutionized healthcare practices. Additionally, the company has successfully obtained regulatory approvals for its flagship drugs and expanded its market presence nationally and internationally. Health Sciences Corp has also established strategic collaborations with renowned organizations, enhancing its research capabilities and furthering advancements in healthcare. These achievements have positioned Health Sciences Corp as a market leader and a trusted name in the industry.

What is the history and background of the company Health Sciences?

Health Sciences Corp is a renowned company in the healthcare industry. Founded several decades ago, it has a rich history of providing cutting-edge medical solutions and improving patient care. Specializing in various medical disciplines, Health Sciences Corp has emerged as a global leader in healthcare innovation. Throughout its history, the company has demonstrated a strong commitment to research and development, fostering collaborations with prominent medical institutions. With a diverse portfolio of products and services, Health Sciences Corp continues to revolutionize the healthcare landscape and contribute significantly to the well-being of individuals worldwide.

Who are the main competitors of Health Sciences in the market?

The main competitors of Health Sciences Corp in the market include notable companies like Johnson & Johnson, Pfizer, Novartis, and Merck & Co. These competitors operate in the pharmaceutical and healthcare industry, offering similar products and services. Health Sciences Corp faces competitive challenges in terms of research and development, market share, and innovation from these industry rivals. By continually striving to provide cutting-edge healthcare solutions, Health Sciences Corp aims to maintain a strong competitive position in the market.

In which industries is Health Sciences primarily active?

Health Sciences Corp is primarily active in the healthcare and pharmaceutical industries. Its focus lies in conducting advanced research, development, and commercialization of innovative solutions that address critical medical needs. By leveraging cutting-edge technologies and partnering with renowned medical institutions, Health Sciences Corp aims to revolutionize patient care and improve health outcomes. With its extensive expertise and commitment to scientific advancements, Health Sciences Corp continues to make significant contributions to the ever-evolving healthcare landscape.

What is the business model of Health Sciences?

The business model of Health Sciences Corp focuses on providing innovative healthcare solutions and products. The company combines cutting-edge technology with extensive research and development to deliver superior medical devices, diagnostics, and pharmaceuticals. Health Sciences Corp operates across various segments including medical imaging, healthcare IT, diagnostics, and therapeutics to meet the diverse needs of patients and healthcare providers. By leveraging its expertise and strategic partnerships, Health Sciences Corp aims to improve patient outcomes, enhance healthcare delivery, and contribute to the advancement of the global healthcare industry.

What is the P/E ratio of Health Sciences 2024?

The P/E ratio cannot be calculated for Health Sciences at the moment.

What is the P/S ratio of Health Sciences 2024?

The P/S cannot be calculated for Health Sciences currently.

What is the AlleAktien quality score of Health Sciences?

The AlleAktien quality score for Health Sciences is 2/10.

What is the revenue of Health Sciences 2024?

The revenue cannot currently be calculated for Health Sciences.

How high is the profit of Health Sciences 2024?

The profit cannot currently be calculated for Health Sciences.

What is the business model of Health Sciences

The company Health Sciences Corp is a globally leading provider of diagnostic and therapeutic products. The business model of the company consists of various divisions that focus on the development, manufacturing, and marketing of medical devices, instruments, and procedures. The Medical Devices division specializes in the production of high-tech devices used in medical diagnostics and therapy. These devices include imaging systems such as X-ray, CT, and MRI scanners, as well as other innovative medical instruments. Another important business segment of Health Sciences Corp is the pharmaceutical industry. Here, diverse products are developed and produced for various medical conditions. Targeted medication therapies offer patients the opportunity to effectively manage health problems. In addition to these two strong pillars, there is a third division called Healthcare Services. Here, services related to the medical field are offered, such as consultation, education, and support for medical professionals. Health Sciences Corp develops and manufactures innovative products to meet the needs of patients. Research and development are constantly being advanced to continuously improve medical diagnostic and therapeutic options. The company collaborates closely with other stakeholders in the healthcare sector, such as doctors and hospitals. This close collaboration also enables more effective use of the products in medical practice and improves patient care. Health Sciences Corp is known for its product innovations, such as flow cytometry technology, for which the company was awarded the Nobel Prize. Even today, the company continues to drive research and development of new technologies and procedures. With its wide range of diagnostic and therapeutic products and professionalism in service, Health Sciences Corp offers its customers comprehensive care for health problems. In the age of digitalization, internet-based services have also become an important part of the business model. Health Sciences Corp operates an online platform through which patients can directly access medical experts and consultants. The future for Health Sciences Corp looks promising, as the healthcare sector will continue to grow in importance. The company has a long history of success, allowing it to be among the leading providers of medical diagnostic and therapeutic products in many countries around the world.

What is the Health Sciences dividend?

Health Sciences pays a dividend of 0 USD distributed over payouts per year.

How often does Health Sciences pay dividends?

The dividend cannot currently be calculated for Health Sciences or the company does not pay out a dividend.

What is the Health Sciences ISIN?

The ISIN of Health Sciences is US0010582056.

What is the Health Sciences ticker?

The ticker of Health Sciences is IWKS.

How much dividend does Health Sciences pay?

Over the past 12 months, Health Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Health Sciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Health Sciences?

The current dividend yield of Health Sciences is .

When does Health Sciences pay dividends?

Health Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Health Sciences?

Health Sciences paid dividends every year for the past 0 years.

What is the dividend of Health Sciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Health Sciences located?

Health Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Health Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Health Sciences from 7/5/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/5/2024.

When did Health Sciences pay the last dividend?

The last dividend was paid out on 7/5/2024.

What was the dividend of Health Sciences in the year 2023?

In the year 2023, Health Sciences distributed 0 USD as dividends.

In which currency does Health Sciences pay out the dividend?

The dividends of Health Sciences are distributed in USD.

Other fundamentals and analyses of Health Sciences in the deep dive.

Our stock analysis for Health Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Health Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.